We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Quotient Sciences has acquired Arcinova, a U.K.-based CDMO. Arcinova has 160 employees, and provides drug substance, drug product and bioanalysis services to more than 200 pharma/biopharma customers worldwide.
Arcinova has invested in a Uniqsis FlowSyn continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process.